Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)Study Protocol Published on 2012-09-192024-09-02 Journal: BMC Cancer [Category] 대상포진, [키워드] Multiple myeloma overall survival phase 3 trial proteasome inhibitor refractory Relapsed [DOI] 10.1186/1471-2407-12-415 PMC 바로가기 [Article Type] Study Protocol
Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomibReview Published on 2012-03-232024-09-04 Journal: Molecular pharmacology [Category] 대상포진, [키워드] bortezomib Follicular lymphoma proteasome inhibitor [DOI] 10.2147/PPA.S23241 PMC 바로가기 [Article Type] Review